Protection against influenza B virus infection by immunization with DNA vaccines. (Q45738887)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163667%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Protection against influenza B virus infection by immunization with DNA vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163667%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

0 references

influenza B virus

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163667%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Z Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163667%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Kadowaki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163667%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Y Hagiwara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163667%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T Sata

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163667%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T Kurata

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163667%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Tamura

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163667%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163667%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

number of pages

10

1 reference

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163667%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163667%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

11-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163667%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1446-1455

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163667%20AND%20SRC:MED&resulttype=core&format=json

Immunity to influenza in man

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Influenza at Christ's Hospital: March, 1974.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Structural basis of immune recognition of influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Recombinant neuraminidase vaccine protects against lethal influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Excess mortality from epidemic influenza, 1957-1966.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Serologic Responses and Systemic Reactions in Adults after Vaccination with Bivalent A/Victoria/75-A/New Jersey/76 and Monovalent B/Hong Kong/72 Influenza Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Reactogenicity and Immunogenicity of Bivalent Influenza A and Monovalent Influenza B Virus Vaccines in High-Risk Children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

The Seattle virus watch. IV. Comparative epidemiologic observations of infections with influenza A and B viruses, 1965-1969, in families with young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

The Tecumseh Study of Respiratory Illness. IX. Occurence of influenza in the community, 1966--1971

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Influenza A and B virus infection in infants and young children during the years 1957-1976

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Severe illness with influenza B.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Morbidity and mortality associated with influenza B in the United States, 1979-1980. A report from the Center for Disease Control

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

A nationwide outbreak of Reye's Syndrome. Its epidemiologic relationship of influenza B

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Efficient selection for high-expression transfectants with a novel eukaryotic vector

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Gene transfer into muscle by electroporation in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Plaque assay and primary isolation of influenza a viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Permanent canine kidney (MDCK) cells for isolation and plaque assay of influenza B viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Immunization with purified N1 and N2 influenza virus neuraminidases demonstrates cross-reactivity without antigenic competition

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

Influenza B Virus in Seals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900351-0

7 January 2021

10.1016/S0264-410X(00)00351-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163667%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference